These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28378635)

  • 1. Methylation of the UNC5C gene and its protein expression in colorectal cancer.
    Wu J; Wang G; He B; Chen X; An Y
    Tumour Biol; 2017 Apr; 39(4):1010428317697564. PubMed ID: 28378635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer.
    Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Jan; 29(1):271-3. PubMed ID: 19331160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of the netrin-1 receptor genes UNC5C and DCC detected in advanced colorectal cancer.
    Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Sanada Y
    World J Surg; 2009 May; 33(5):1053-7. PubMed ID: 19242752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies.
    Bernet A; Mazelin L; Coissieux MM; Gadot N; Ackerman SL; Scoazec JY; Mehlen P
    Gastroenterology; 2007 Dec; 133(6):1840-8. PubMed ID: 17967459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in UNC5C gene methylation during human gastric carcinogenesis.
    Hibi K; Sakata M; Sakuraba K; Kitamura YH; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Nov; 29(11):4397-9. PubMed ID: 20032384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
    Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer.
    Shin SK; Nagasaka T; Jung BH; Matsubara N; Kim WH; Carethers JM; Boland CR; Goel A
    Gastroenterology; 2007 Dec; 133(6):1849-57. PubMed ID: 18054557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis.
    Mur P; Sánchez-Cuartielles E; Aussó S; Aiza G; Valdés-Mas R; Pineda M; Navarro M; Brunet J; Urioste M; Lázaro C; Moreno V; Capellá G; Puente XS; Valle L
    Sci Rep; 2016 Feb; 6():20697. PubMed ID: 26852919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant Pattern of Promoter Hypermethylation of UNC5C Gene in Colorectal Cancer and Its Implication in Late Stage Disease.
    Guroo SA; Malik AA; Afroze D; Ali S; Pandith AA; Yusuf A
    Asian Pac J Cancer Prev; 2018 May; 19(5):1185-1188. PubMed ID: 29801399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MGMT gene is aberrantly methylated from the early stages of colorectal cancers.
    Hibi K; Goto T; Mizukami H; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Hepatogastroenterology; 2009; 56(96):1642-4. PubMed ID: 20214209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the UNC5C gene is frequently detected in hepatocellular carcinoma.
    Hibi K; Sakuraba K; Shirahata A; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Hepatogastroenterology; 2012; 59(120):2573-5. PubMed ID: 23178624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
    Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
    Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
    Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF
    Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation-mediated repression of UNC5 receptors and the associated clinical significance in human colorectal cancer.
    Dong D; Zhang R; Shao J; Zhang A; Wang Y; Zhou Y; Li Y
    Clin Epigenetics; 2021 Dec; 13(1):225. PubMed ID: 34922605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
    Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
    Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.
    Tamagawa H; Oshima T; Numata M; Yamamoto N; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Yukawa N; Rino Y; Masuda M; Miyagi Y
    Eur J Surg Oncol; 2013 Jun; 39(6):655-61. PubMed ID: 23523318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
    Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
    BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
    Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
    Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?
    Colakoglu T; Yildirim S; Kayaselcuk F; Nursal TZ; Ezer A; Noyan T; Karakayali H; Haberal M
    Am J Surg; 2008 Jun; 195(6):719-25. PubMed ID: 18440486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.